B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MARS2

MOLECULAR TARGET

methionyl-tRNA synthetase 2, mitochondrial

UniProt: Q96GW9NCBI Gene: 929351 compounds

MARS2 (methionyl-tRNA synthetase 2, mitochondrial) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MARS2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Chloramphenicol0.691

About MARS2 as a Drug Target

MARS2 (methionyl-tRNA synthetase 2, mitochondrial) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented MARS2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MARS2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.